{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:39:40Z","timestamp":1648604380423},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1331\/japha.2015.14263","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T21:38:09Z","timestamp":1422049089000},"page":"122-124","source":"Crossref","is-referenced-by-count":0,"title":["Association of subarachnoid hemorrhage and phentermine usage: Coincidence, not causation"],"prefix":"10.1016","volume":"55","author":[{"given":"Ed J.","family":"Hendricks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Bryman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy L.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2015.14263_bb0010","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1331\/JAPhA.2014.13226","article-title":"Subarachnoid hemorrhage in a patient taking phentermine for weight loss","volume":"54","author":"Bain","year":"2014","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1331\/JAPhA.2015.14263_bb0015","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/oby.2009.69","article-title":"How physician obesity specialists use drugs to treat obesity","volume":"17","author":"Hendricks","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1331\/JAPhA.2015.14263_bb0020","article-title":"How physician obesity medicine specialists treated obesity before 2012 new drug approvals","author":"Schmidt","year":"2014","journal-title":"Obes Surg"},{"key":"10.1331\/JAPhA.2015.14263_bb0025","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/phar.1342","article-title":"Use of prescription antiobesity drugs in the United States","volume":"33","author":"Hampp","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1331\/JAPhA.2015.14263_bb0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.annepidem.2012.01.001","article-title":"Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007\u20132008","volume":"22","author":"Samaranayake","year":"2012","journal-title":"Ann Epidemiol"},{"key":"10.1331\/JAPhA.2015.14263_bb0035","first-page":"14","article-title":"Incidences of unruptured intracranial aneurysms and subarachnoid hemorrhage: results of a statewide study","volume":"7","author":"Asaithambi","year":"2014","journal-title":"J Vasc Interv Neurol"},{"key":"10.1331\/JAPhA.2015.14263_bb0040","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/oby.2011.94","article-title":"Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity","volume":"19","author":"Hendricks","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1331\/JAPhA.2015.14263_bb0045","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1463-1326.2011.01435.x","article-title":"Phentermine therapy for obesity does not elevate blood pressure","volume":"13","author":"Hendricks","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1331\/JAPhA.2015.14263_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0893-133X(95)00113-R","article-title":"Evaluation of phentermine and fenfluramine, alone and in combination, in normal, healthy volunteers","volume":"14","author":"Brauer","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1331\/JAPhA.2015.14263_bb0055","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1177\/0091270009341651","article-title":"Pharmacokinetics, safety, and tolerability of phentermine in healthy participants receiving taranabant, a novel cannabinoid-1 receptor (CB1R) inverse agonist","volume":"49","author":"Addy","year":"2009","journal-title":"J Clin Pharmacol"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115300327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115300327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T03:22:51Z","timestamp":1537932171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115300327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1544319115300327"],"URL":"https:\/\/doi.org\/10.1331\/japha.2015.14263","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}